ANDEXXA
- Product NDC
- 69853-0102
- 11-digit product format
- 698530102
- Labeler code
- 69853
- Product ID
- 69853-0102_6e8a9040-9ed4-4ef6-b782-1898fce3f76e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- andexanet alfa
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Alexion Pharmaceuticals, Inc.
- Application
- BLA125586
- Marketing category
- BLA
- Marketing start
- 2019-01-08
- Marketing end
- 2024-11-30
- Substance
- ANDEXANET ALFA
- Active strength
- 200 mg/20mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69853-0102-1 | 69853010201 | 4 VIAL, SINGLE-USE in 1 CARTON (69853-0102-1) > 20 mL in 1 VIAL, SINGLE-USE | 2019-01-08 | 0000-00-00 | No | No | Current |